新冠“乙类乙管”政策下临床生物样本保藏及生物安全防护专家共识  

Expert Consensus on Clinical Specimen Preservation and Biosafety Protection in the Context of Managing COVID-19 with Measures against Class B Infectious Diseases

作　　者：中国研究型医院学会临床数据与样本资源库专业委员会 广东省人类遗传资源保藏应用学会 刘妍 孙海涛[3] 孔晶晶 李昕 张晖 Clinical Data and Biobank Committee of China Research Hospital Association;Guangdong Human Genetic Resource Biobanking and Applications Association;LIU Yan;SUN Haitao(不详;Department of Infectious Diseases,Biobank of the National Clinical Research Center for Infectious Diseases,the Fifth Medical Center of Chinese PLA General Hospital,Beijing 100039,China;Clinical biobank Center,Southern Medical University Zhujiang Hospital,Guangzhou 510280,China)

机构地区：[1]不详 [2]解放军总医院第五医学中心国家感染性疾病临床医学研究中心生物样本资源库,北京100039 [3]南方医科大学珠江医院临床生物样本资源中心,广州510280

出　　处：《协和医学杂志》2023年第5期972-977,共6页Medical Journal of Peking Union Medical College Hospital

基　　金：国家自然科学基金(81721002)。

摘　　要：随着新型冠状病毒感染(coronavirus disease 2019,COVID-19)的流行,国家对其防控政策历经“乙类甲管”至“乙类乙管”。在此背景下,生物样本库开展样本保藏活动时,需重新审视其带来的生物安全风险,并开展相应的生物安全防护实践,制订有效的管理措施。针对新型冠状病毒不断变异的特性和潜在风险,完善生物安全防护体系势在必行。中国研究型医院学会临床数据与样本资源库专业委员会和广东省人类遗传资源保藏应用学会共同起草并制定本共识,旨在为临床生物样本保藏活动提供安全防护实践指引,降低生物安全风险,确保临床生物样本保藏活动的安全顺利开展。During the past three years, the national prevention and control policies for coronavirus disease 2019(COVID-19) have gone from“Class A control” to “Class B control”. Therefore, it is necessary to reexamine the biosafety risks, carry out corresponding biosafety protection practices, and formulate management measures for clinical Biobank when conducting sample preservation activities. It is imperative to improve the biosafety protection system in view of the constantly mutating characteristics and potential risks of novel coronavirus. Professional Committee of Clinical Data and Sample Resource Database of China Research Hospital Association and the Human Genetic Resource Conservation and Application Society of Guangdong Province jointly drafted and formulated this consensus. We aim to provide practical guidance on biosafety protection for sample preservation activities, reduce biosafety risks, and ensure the safe and efficient implementation of sample preservation activities.

关 键 词：新型冠状病毒 乙类传染病 临床生物样本库 生物安全风险 生物安全防护 

分 类 号：R183[医药卫生—流行病学] Q-34[医药卫生—公共卫生与预防医学] Q95-345[生物学]